Tag: Trial

America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.

Recon Technology (NASDAQ:RCON) stock dips below 200-day average, hits $1.38; analysts issue "sell" rating, highlighting cautious future outlook.

Tech sector dip pulls S&P 500 and Nasdaq; Nvidia drops over 3%, marking significant impact. Dow ends week up; US ...

Alaska judge upholds most fines against opponents of ranked choice voting and open primaries for violating campaign finance disclosure rules.

"Ethereum dips 1% amid SEC updates, Polygon sees rising locked assets, and XRP struggles below $0.50 due to CEO's legal ...

Eli Lilly's Zepbound reduces sleep apnea by up to 52% in trials, showing promise beyond weight loss. FDA approval for ...

BYD highlights advanced renewable energy solutions at The Smarter E Europe, unveils new innovations and celebrates UEFA Euro 2024 E-Mobility ...

Article reveals Habersham County Development Authority faced financial loss on land deal for cryptocurrency data center due to unforeseen costs.

Zealand Pharma's stock surged 17% post-positive trial results for its weight loss drug, showing promising 8.6% average weight reduction. Analysts ...

Explore the Q3 2024 commodity forecast. Discover trends in oil, gold, copper, and natural gas prices and their implications for ...